Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
5961.0000 -31.00 (-0.52%)
NSE Aug 12, 2025 15:31 PM
Volume: 477.8K
 

5961.00
-0.52%
Phillip Capital
Divi's Q1FY16 operating performance was just in line with our estimates with 26%/32% growth in sales/adjusted profit. Going ahead, the management expects to maintainsteadygrowthledbyprocessimprovementintheexistinggenericmolecules...
Divi's Laboratories .. has an average target of 6447.40 from 5 brokers.
More from Divi's Laboratories Ltd.
Recommended